Filing Flows › Bristol Myers Squibb (BMY) › Q3 2026
Bristol Myers Squibb (BMY) Q3 2026 earnings results (third quarter 2026)
10-Q filed Oct 29, 2026
Bristol Myers Squibb (BMY) reported revenue of $13.1B for the third quarter 2026 (Q3 2026), +7% from a year earlier and +0.7% from the quarter before. Operating margin was 19.4%, net earnings $2.2B (16.5% of revenue).
Bristol Myers Squibb, Q3 2026: revenue $13.1B (+7% year over year), operating margin 19.4%, net earnings $2.2B, operating cash flow $4.2B. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.1B | +0.7% | +7% |
| Operating profit | $2.5B | -38% | -19% |
| Net earnings | $2.2B | -35% | -2% |
| Operating cash flow | $4.2B | +23% | -34% |
| Free cash flow | $3.8B | +24% | -36% |
What changed
Revenue was $13.1B in Q3 2026, up 7% year over year and up 1% from the previous quarter. Legacy Portfolio was the largest line at 41% of revenue. Eliquis added $0.94B year over year (up 25%), 111% of the total change.
Operating profit was $2.5B, a 19.4% margin (down 6.1 points year over year). Operating profit fell $0.58B even though revenue rose $0.85B versus Q3 2025, so costs grew faster than sales. Total costs grew 16% against revenue growth of 7%. The fastest-growing cost line was Other operating costs (+71%). Net earnings were $2.2B, down 2% year over year. The effective tax rate was 14.7%.
Operating cash flow was $4.2B (down 34% year over year), 193% of net earnings. Non-cash charges added back $0.63B of depreciation and amortization and $0.14B of share-based compensation. Working capital and other items added $1.3B. Capital expenditures of $0.34B left free cash flow of $3.8B.
Questions
What was Bristol Myers Squibb's revenue in the third quarter 2026?
Bristol Myers Squibb (BMY) reported revenue of $13.1B for the third quarter 2026 (Q3 2026), +7% from a year earlier and +0.7% from the quarter before.
Was Bristol Myers Squibb profitable in the third quarter 2026?
Operating profit was $2.5B (19.4% of revenue) and net earnings $2.2B.